410 related articles for article (PubMed ID: 21926931)
1. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
[TBL] [Abstract][Full Text] [Related]
2. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
3. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
4. Clinical parameters linked with malignancy in endometrial polyps.
Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
[TBL] [Abstract][Full Text] [Related]
5. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
[TBL] [Abstract][Full Text] [Related]
6. The malignant potential of endometrial polyps.
Ben-Arie A; Goldchmit C; Laviv Y; Levy R; Caspi B; Huszar M; Dgani R; Hagay Z
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):206-10. PubMed ID: 15262357
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of 42 cases of malignant endometrial polyps].
Tang Z; Zhou R; Bao D; Liu C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
[TBL] [Abstract][Full Text] [Related]
9. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.
Wang JH; Zhao J; Lin J
J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333
[TBL] [Abstract][Full Text] [Related]
11. The contribution of hysteroscopy to the detection malignancy in symptomatic postmenopausal women.
Liberis V; Tsikouras P; Christos Z; Ammari A; Dislian V; Koutlaki N; Liberis A; Maroulis G
Minim Invasive Ther Allied Technol; 2010 Apr; 19(2):83-93. PubMed ID: 20158408
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of postmenopausal uterine bleeding by hysteroscopy].
Liu Y; Zhou Y; Wen H
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):732-4. PubMed ID: 8728918
[TBL] [Abstract][Full Text] [Related]
13. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
14. Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps.
Rahimi S; Marani C; Renzi C; Natale ME; Giovannini P; Zeloni R
Int J Gynecol Pathol; 2009 Nov; 28(6):522-8. PubMed ID: 19851198
[TBL] [Abstract][Full Text] [Related]
15. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
17. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
18. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
[TBL] [Abstract][Full Text] [Related]
19. [Hysteroscopic evaluation of the uterine cavity in postmenopausal women with uterine bleeding].
Wierzbowski T; Gottwald L; Bieńkiewicz A; Suzin J
Ginekol Pol; 2003 Sep; 74(9):892-6. PubMed ID: 14674141
[TBL] [Abstract][Full Text] [Related]
20. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]